BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 23160199)

  • 1. Viperin restricts chikungunya virus replication and pathology.
    Teng TS; Foo SS; Simamarta D; Lum FM; Teo TH; Lulla A; Yeo NK; Koh EG; Chow A; Leo YS; Merits A; Chin KC; Ng LF
    J Clin Invest; 2012 Dec; 122(12):4447-60. PubMed ID: 23160199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct Roles of Interferon Alpha and Beta in Controlling Chikungunya Virus Replication and Modulating Neutrophil-Mediated Inflammation.
    Cook LE; Locke MC; Young AR; Monte K; Hedberg ML; Shimak RM; Sheehan KCF; Veis DJ; Diamond MS; Lenschow DJ
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31619554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of dengue and chikungunya virus infections by RIG-I-mediated type I interferon-independent stimulation of the innate antiviral response.
    Olagnier D; Scholte FE; Chiang C; Albulescu IC; Nichols C; He Z; Lin R; Snijder EJ; van Hemert MJ; Hiscott J
    J Virol; 2014 Apr; 88(8):4180-94. PubMed ID: 24478443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response.
    Hawman DW; Stoermer KA; Montgomery SA; Pal P; Oko L; Diamond MS; Morrison TE
    J Virol; 2013 Dec; 87(24):13878-88. PubMed ID: 24131709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residue 82 of the Chikungunya virus E2 attachment protein modulates viral dissemination and arthritis in mice.
    Ashbrook AW; Burrack KS; Silva LA; Montgomery SA; Heise MT; Morrison TE; Dermody TS
    J Virol; 2014 Nov; 88(21):12180-92. PubMed ID: 25142598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Methyltransferase-Like Domain of Chikungunya Virus nsP2 Inhibits the Interferon Response by Promoting the Nuclear Export of STAT1.
    Göertz GP; McNally KL; Robertson SJ; Best SM; Pijlman GP; Fros JJ
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon Alpha, but Not Interferon Beta, Acts Early To Control Chronic Chikungunya Virus Pathogenesis.
    Locke MC; Fox LE; Dunlap BF; Young AR; Monte K; Lenschow DJ
    J Virol; 2022 Jan; 96(1):e0114321. PubMed ID: 34668781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chikungunya virus infection results in higher and persistent viral replication in aged rhesus macaques due to defects in anti-viral immunity.
    Messaoudi I; Vomaske J; Totonchy T; Kreklywich CN; Haberthur K; Springgay L; Brien JD; Diamond MS; Defilippis VR; Streblow DN
    PLoS Negl Trop Dis; 2013; 7(7):e2343. PubMed ID: 23936572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-alpha/beta deficiency greatly exacerbates arthritogenic disease in mice infected with wild-type chikungunya virus but not with the cell culture-adapted live-attenuated 181/25 vaccine candidate.
    Gardner CL; Burke CW; Higgs ST; Klimstra WB; Ryman KD
    Virology; 2012 Apr; 425(2):103-12. PubMed ID: 22305131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chikungunya virus arthritis in adult wild-type mice.
    Gardner J; Anraku I; Le TT; Larcher T; Major L; Roques P; Schroder WA; Higgs S; Suhrbier A
    J Virol; 2010 Aug; 84(16):8021-32. PubMed ID: 20519386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active infection of human blood monocytes by Chikungunya virus triggers an innate immune response.
    Her Z; Malleret B; Chan M; Ong EK; Wong SC; Kwek DJ; Tolou H; Lin RT; Tambyah PA; Rénia L; Ng LF
    J Immunol; 2010 May; 184(10):5903-13. PubMed ID: 20404274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cell immunoreceptor regulates Chikungunya virus pathogenesis in mice.
    Long KM; Whitmore AC; Ferris MT; Sempowski GD; McGee C; Trollinger B; Gunn B; Heise MT
    J Virol; 2013 May; 87(10):5697-706. PubMed ID: 23487448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host oxidative folding pathways offer novel anti-chikungunya virus drug targets with broad spectrum potential.
    Langsjoen RM; Auguste AJ; Rossi SL; Roundy CM; Penate HN; Kastis M; Schnizlein MK; Le KC; Haller SL; Chen R; Watowich SJ; Weaver SC
    Antiviral Res; 2017 Jul; 143():246-251. PubMed ID: 28461071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Mutations in nsP2 Abolish Chikungunya Virus-Induced Transcriptional Shutoff and Make the Virus Less Cytopathic without Affecting Its Replication Rates.
    Akhrymuk I; Lukash T; Frolov I; Frolova EI
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes.
    Pal P; Fox JM; Hawman DW; Huang YJ; Messaoudi I; Kreklywich C; Denton M; Legasse AW; Smith PP; Johnson S; Axthelm MK; Vanlandingham DL; Streblow DN; Higgs S; Morrison TE; Diamond MS
    J Virol; 2014 Aug; 88(15):8213-26. PubMed ID: 24829346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chikungunya virus host range E2 transmembrane deletion mutants induce protective immunity against challenge in C57BL/6J mice.
    Piper A; Ribeiro M; Smith KM; Briggs CM; Huitt E; Nanda K; Spears CJ; Quiles M; Cullen J; Thomas ME; Brown DT; Hernandez R
    J Virol; 2013 Jun; 87(12):6748-57. PubMed ID: 23552427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice.
    Hallengärd D; Kakoulidou M; Lulla A; Kümmerer BM; Johansson DX; Mutso M; Lulla V; Fazakerley JK; Roques P; Le Grand R; Merits A; Liljeström P
    J Virol; 2014 Mar; 88(5):2858-66. PubMed ID: 24371047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of TLR mediated innate immune response of mouse neuronal cells following infection with novel ECSA genotype of Chikungunya virus with and without E1:A226V mutation.
    Priya R; Dhanwani R; Patro IK; Rao PV; Parida MM
    Infect Genet Evol; 2013 Dec; 20():396-406. PubMed ID: 24126361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation Sites in the Hypervariable Domain in Chikungunya Virus nsP3 Are Crucial for Viral Replication.
    Teppor M; Žusinaite E; Merits A
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33568506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia.
    Dupuis-Maguiraga L; Noret M; Brun S; Le Grand R; Gras G; Roques P
    PLoS Negl Trop Dis; 2012; 6(3):e1446. PubMed ID: 22479654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.